FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085759552> ?p ?o ?g. }

• W2085759552 endingPage "245" @default.
• W2085759552 startingPage "237" @default.
• W2085759552 abstract "Sjögren's syndrome, an autoimmune disease that occurs primarily in women, causes extensive inflammation and significant dysfunction in the lacrimal gland, and is one of the leading causes of dry eye syndromes throughout the world. Recently, our research has shown that androgen treatment causes a significant suppression of the immunopathological lesions in lacrimal tissues of female mouse models (MRL/Mp-lpr/lpr [MRL/lpr] and NZB/NZW F1 [F1]) of Sjögren's syndrome. To extend these findings, the objective of the present study was to determine whether this androgen-induced anti-inflammatory action may be paralleled by an increase in the functional activity of lacrimal glands in these autoimmune mice. Towards this end, we measured the tear levels of immunoglobulin A (IgA), which originates from lacrimal tissue and whose concentration is known to be diminished in mucosal sites in Sjögren's syndrome. For comparative purposes, we also evaluated whether the administration of other steroid hormones or immunosuppressive agents might duplicate possible androgen effects on the secretory function of lacrimal tissue. Female MRL/lpr and F1, as well as non-autoimmune BALB/c, mice were treated with vehicle, steroids or immunosuppressive compounds for 17 to 54 days after the onset of disease. Lacrimal glands, tears and sera were collected immediately before (pretreatment), or after, therapy and processed for the analysis of either tear IgA (enzyme-linked immunosorbent assay; ELISA) and protein content or the magnitude of lymphocyte infiltration (computer-assisted image analysis). Our findings demonstrated that testosterone treatment stimulated a significant increase in the concentration and total amount of tear IgA, as well as tear protein, compared to levels in pretreatment or placebo controls. This hormone action was reproduced by exposure to a diverse array of anabolic and androgenic androgen analogues, but not by treatment with estradiol, danazol, cyclosporine A, dexamethasone or cyclophosphamide. In contrast, only dexamethasone increased serum IgA concentrations. Of particular interest is the fact that the androgen control of IgA output by the lacrimal gland appeared to be independent of this steroid's suppression of lymphocyte infiltration in lacrimal tissue. Overall, these results show that androgen therapy enhances the functional activity of the lacrimal gland in mouse models of Sjögren's syndrome." @default.
• W2085759552 created "2016-06-24" @default.
• W2085759552 creator A5012683360 @default.
• W2085759552 creator A5028478656 @default.
• W2085759552 date "1997-02-01" @default.
• W2085759552 modified "2023-10-06" @default.
• W2085759552 title "Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome" @default.
• W2085759552 cites W142968270 @default.
• W2085759552 cites W1510045927 @default.
• W2085759552 cites W1517426366 @default.
• W2085759552 cites W1552635305 @default.
• W2085759552 cites W1602319236 @default.
• W2085759552 cites W1621773313 @default.
• W2085759552 cites W1949482848 @default.
• W2085759552 cites W1963558638 @default.
• W2085759552 cites W1974667009 @default.
• W2085759552 cites W1984813622 @default.
• W2085759552 cites W1987226737 @default.
• W2085759552 cites W1991574617 @default.
• W2085759552 cites W1998270868 @default.
• W2085759552 cites W2014281089 @default.
• W2085759552 cites W2018120069 @default.
• W2085759552 cites W2030165509 @default.
• W2085759552 cites W2032663210 @default.
• W2085759552 cites W2039672722 @default.
• W2085759552 cites W2046123379 @default.
• W2085759552 cites W2047838479 @default.
• W2085759552 cites W2066863443 @default.
• W2085759552 cites W2074923888 @default.
• W2085759552 cites W2102956677 @default.
• W2085759552 cites W2103043404 @default.
• W2085759552 cites W2138733175 @default.
• W2085759552 cites W2158224186 @default.
• W2085759552 cites W287173177 @default.
• W2085759552 doi "https://doi.org/10.1016/s0960-0760(96)00190-2" @default.
• W2085759552 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9191982" @default.
• W2085759552 hasPublicationYear "1997" @default.
• W2085759552 type Work @default.
• W2085759552 sameAs 2085759552 @default.
• W2085759552 citedByCount "86" @default.
• W2085759552 countsByYear W20857595522013 @default.
• W2085759552 countsByYear W20857595522014 @default.
• W2085759552 countsByYear W20857595522015 @default.
• W2085759552 countsByYear W20857595522016 @default.
• W2085759552 countsByYear W20857595522017 @default.
• W2085759552 countsByYear W20857595522019 @default.
• W2085759552 countsByYear W20857595522020 @default.
• W2085759552 countsByYear W20857595522021 @default.
• W2085759552 countsByYear W20857595522022 @default.
• W2085759552 countsByYear W20857595522023 @default.
• W2085759552 crossrefType "journal-article" @default.
• W2085759552 hasAuthorship W2085759552A5012683360 @default.
• W2085759552 hasAuthorship W2085759552A5028478656 @default.
• W2085759552 hasConcept C126322002 @default.
• W2085759552 hasConcept C134018914 @default.
• W2085759552 hasConcept C142724271 @default.
• W2085759552 hasConcept C159654299 @default.
• W2085759552 hasConcept C203014093 @default.
• W2085759552 hasConcept C24998067 @default.
• W2085759552 hasConcept C2777911890 @default.
• W2085759552 hasConcept C2778214642 @default.
• W2085759552 hasConcept C2778275304 @default.
• W2085759552 hasConcept C2779075594 @default.
• W2085759552 hasConcept C2779134260 @default.
• W2085759552 hasConcept C2779298748 @default.
• W2085759552 hasConcept C2779665388 @default.
• W2085759552 hasConcept C2780130043 @default.
• W2085759552 hasConcept C2780750233 @default.
• W2085759552 hasConcept C49039625 @default.
• W2085759552 hasConcept C71315377 @default.
• W2085759552 hasConcept C71924100 @default.
• W2085759552 hasConceptScore W2085759552C126322002 @default.
• W2085759552 hasConceptScore W2085759552C134018914 @default.
• W2085759552 hasConceptScore W2085759552C142724271 @default.
• W2085759552 hasConceptScore W2085759552C159654299 @default.
• W2085759552 hasConceptScore W2085759552C203014093 @default.
• W2085759552 hasConceptScore W2085759552C24998067 @default.
• W2085759552 hasConceptScore W2085759552C2777911890 @default.
• W2085759552 hasConceptScore W2085759552C2778214642 @default.
• W2085759552 hasConceptScore W2085759552C2778275304 @default.
• W2085759552 hasConceptScore W2085759552C2779075594 @default.
• W2085759552 hasConceptScore W2085759552C2779134260 @default.
• W2085759552 hasConceptScore W2085759552C2779298748 @default.
• W2085759552 hasConceptScore W2085759552C2779665388 @default.
• W2085759552 hasConceptScore W2085759552C2780130043 @default.
• W2085759552 hasConceptScore W2085759552C2780750233 @default.
• W2085759552 hasConceptScore W2085759552C49039625 @default.
• W2085759552 hasConceptScore W2085759552C71315377 @default.
• W2085759552 hasConceptScore W2085759552C71924100 @default.
• W2085759552 hasIssue "3-4" @default.
• W2085759552 hasLocation W20857595521 @default.
• W2085759552 hasLocation W20857595522 @default.
• W2085759552 hasOpenAccess W2085759552 @default.
• W2085759552 hasPrimaryLocation W20857595521 @default.
• W2085759552 hasRelatedWork W1247577190 @default.
• W2085759552 hasRelatedWork W1977144908 @default.
• W2085759552 hasRelatedWork W1979452793 @default.
• W2085759552 hasRelatedWork W1999231041 @default.

• next